Case Report: Mucosal Leishmaniasis in New York City

Am J Trop Med Hyg. 2020 Jun;102(6):1319-1322. doi: 10.4269/ajtmh.19-0861.

Abstract

The six previously reported civilian cases of mucosal leishmaniasis (ML) diagnosed in the United States have all represented imported New World ML. We describe two new patients with ML diagnosed in New York City-a Syrian immigrant with a nasal mass (Leishmania tropica), the first report of Old World ML in the United States, and an American ecologist who worked in Bolivia and had been treated for cutaneous infection 23 years before developing lesions (L. (Viannia) braziliensis) initially of the uvula, soft palate, and posterior pharynx and subsequently the larynx.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amphotericin B / therapeutic use
  • Antiprotozoal Agents / therapeutic use
  • Humans
  • Leishmania braziliensis / isolation & purification
  • Leishmaniasis, Mucocutaneous / drug therapy
  • Leishmaniasis, Mucocutaneous / epidemiology*
  • Leishmaniasis, Mucocutaneous / pathology*
  • Male
  • Middle Aged
  • New York City / epidemiology
  • Phosphorylcholine / analogs & derivatives
  • Phosphorylcholine / therapeutic use

Substances

  • Antiprotozoal Agents
  • liposomal amphotericin B
  • Phosphorylcholine
  • miltefosine
  • Amphotericin B